Davis Jefferson E 4
4 · Acer Therapeutics Inc. · Filed Jan 19, 2022
Insider Transaction Report
Form 4
Davis Jefferson E
Chief Business Officer
Transactions
- Award
Employee Stock Option (right to buy)
2022-01-14+25,000→ 25,000 totalExercise: $2.21Exp: 2032-01-14→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable over four years as follows: 25% of the shares vest on January 14, 2023, and the remaining 75% of the shares vest quarterly over the remaining three years.